Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine

Vaccine solutions rarely reach the public until after an outbreak abates; an Ebola vaccine was approved 5 years after peak outbreak and SARS, MERS, and Zika vaccines are still in clinical development. Despite massive leaps forward in rapid science, other regulatory bottlenecks are hamstringing the g...

Descripción completa

Detalles Bibliográficos
Autores principales: Pregelj, Lisette, Hine, Damian C., Oyola-Lozada, Maria G., Munro, Trent P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Science & Society
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293492/
https://www.ncbi.nlm.nih.gov/pubmed/32600777
http://dx.doi.org/10.1016/j.tibtech.2020.06.004
_version_ 1783546317448937472
author Pregelj, Lisette
Hine, Damian C.
Oyola-Lozada, Maria G.
Munro, Trent P.
author_facet Pregelj, Lisette
Hine, Damian C.
Oyola-Lozada, Maria G.
Munro, Trent P.
author_sort Pregelj, Lisette
collection PubMed
description Vaccine solutions rarely reach the public until after an outbreak abates; an Ebola vaccine was approved 5 years after peak outbreak and SARS, MERS, and Zika vaccines are still in clinical development. Despite massive leaps forward in rapid science, other regulatory bottlenecks are hamstringing the global effort for pandemic vaccines.
format Online
Article
Text
id pubmed-7293492
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72934922020-06-14 Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine Pregelj, Lisette Hine, Damian C. Oyola-Lozada, Maria G. Munro, Trent P. Trends Biotechnol Science & Society Vaccine solutions rarely reach the public until after an outbreak abates; an Ebola vaccine was approved 5 years after peak outbreak and SARS, MERS, and Zika vaccines are still in clinical development. Despite massive leaps forward in rapid science, other regulatory bottlenecks are hamstringing the global effort for pandemic vaccines. Elsevier Ltd. 2020-09 2020-06-13 /pmc/articles/PMC7293492/ /pubmed/32600777 http://dx.doi.org/10.1016/j.tibtech.2020.06.004 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Science & Society
Pregelj, Lisette
Hine, Damian C.
Oyola-Lozada, Maria G.
Munro, Trent P.
Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine
title Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine
title_full Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine
title_fullStr Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine
title_full_unstemmed Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine
title_short Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine
title_sort working hard or hardly working? regulatory bottlenecks in developing a covid-19 vaccine
topic Science & Society
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293492/
https://www.ncbi.nlm.nih.gov/pubmed/32600777
http://dx.doi.org/10.1016/j.tibtech.2020.06.004
work_keys_str_mv AT pregeljlisette workinghardorhardlyworkingregulatorybottlenecksindevelopingacovid19vaccine
AT hinedamianc workinghardorhardlyworkingregulatorybottlenecksindevelopingacovid19vaccine
AT oyolalozadamariag workinghardorhardlyworkingregulatorybottlenecksindevelopingacovid19vaccine
AT munrotrentp workinghardorhardlyworkingregulatorybottlenecksindevelopingacovid19vaccine

Ejemplares similares